speb/financial-data huggingface dataset:
IBKR cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -76000000.00
IBKR cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
IBKR balance_sheet (annual, 2025-12-31) — Working Capital: 20814000000.00
IBKR balance_sheet (quarterly, 2025-12-31) — Working Capital: 20814000000.00
IBKR income_statement (annual, 2025-12-31) — Write Off: 1000000.00
IBKR income_statement (quarterly, 2025-12-31) — Write Off: 1000000.00
IBKR income_statement (quarterly, 2026-03-31) — +Operating Expense: 107000000.00
IBKR income_statement (quarterly, 2026-03-31) — +Total Revenue: 2646000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 164414000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 86544000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 537000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1965000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -25000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 1000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 24041000000.00
IBKR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 445000000.00
IBKR income_statement (quarterly, 2026-03-31) — Basic EPS: 0.60
IBKR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 55295000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -26000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5085000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5085000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -36000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -316000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -12000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3611000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 8623000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 1361000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 7039000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -15368000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Payable: 7692000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 7692000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1638000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2362000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3929000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3283000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -36000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5585000000.00
IBKR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 273000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 315000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Current Assets: 193031000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Current Debt: 12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 164959000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Depreciation: 25000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 25000000.00
IBKR income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 27000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 25000000.00
IBKR income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 27000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 514000000.00
IBKR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 452542373.00
IBKR income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.59
IBKR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 267000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 18000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 218000000.00
IBKR income_statement (quarterly, 2026-03-31) — EBIT: 2331000000.00
IBKR income_statement (quarterly, 2026-03-31) — EBITDA: 2358000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -79000000.00
IBKR cash_flow (quarterly, 2026-03-31) — End Cash Position: 58499000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -316000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3585000000.00
IBKR income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 26000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 35000000.00
IBKR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 80000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 86569000000.00
IBKR income_statement (quarterly, 2026-03-31) — Gross Profit: 2373000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 15000000.00
IBKR income_statement (quarterly, 2026-03-31) — Interest Expense: 1043000000.00
IBKR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1043000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1049000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Interest Payable: 315000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5597000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 24041000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 24041000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Minority Interest: 15675000000.00
IBKR income_statement (quarterly, 2026-03-31) — Minority Interests: -904000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income: 267000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 267000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1171000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 267000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 267000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1171000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1171000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Interest Income: -1043000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -4000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -7000000.00
IBKR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1043000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -273000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -26000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -7000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5585000000.00
IBKR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2333000000.00
IBKR income_statement (quarterly, 2026-03-31) — Normalized Income: 244270962.73
IBKR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3611000000.00
IBKR income_statement (quarterly, 2026-03-31) — Operating Income: 2266000000.00
IBKR income_statement (quarterly, 2026-03-31) — Operating Revenue: 2560000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 445475099.00
IBKR balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 35000000.00
IBKR income_statement (quarterly, 2026-03-31) — Other Gand A: 80000000.00
IBKR income_statement (quarterly, 2026-03-31) — Other Income Expense: 65000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1677000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 32016000000.00
IBKR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 40000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Other Receivables: 5405000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Payables: 164632000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 164947000000.00
IBKR income_statement (quarterly, 2026-03-31) — Pretax Income: 1288000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -26000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Receivables: 92486000000.00
IBKR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 275000000.00
IBKR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 25000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 95460000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3596000000.00
IBKR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 80000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Share Issued: 446134506.00
IBKR income_statement (quarterly, 2026-03-31) — Special Income Charges: -1000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 33000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5585000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5585000000.00
IBKR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 2270962.73
IBKR income_statement (quarterly, 2026-03-31) — Tax Provision: 117000000.00
IBKR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.09
IBKR balance_sheet (quarterly, 2026-03-31) — Total Assets: 218749000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5585000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Debt: 12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 21260000000.00
IBKR income_statement (quarterly, 2026-03-31) — Total Expenses: 380000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 197489000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 25718000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 32530000000.00
IBKR income_statement (quarterly, 2026-03-31) — Total Unusual Items: 25000000.00
IBKR income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 25000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 659407.00
IBKR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 12000000.00
IBKR cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 12000000.00
IBKR balance_sheet (quarterly, 2026-03-31) — Working Capital: 28072000000.00
IBKR income_statement (quarterly, 2026-03-31) — Write Off: 1000000.00
IBKR income_statement (quarterly, 2026-06-30) — Basic Average Shares: 445714286.00
IBKR income_statement (quarterly, 2026-06-30) — Basic EPS: 0.70
IBKR income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 452173913.00
IBKR income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.69
IBM income_statement (annual, 2021-12-31) — Average Dilution Earnings: 0.00
IBM balance_sheet (annual, 2021-12-31) — Financial Assets: 40000000.00
IBM income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 35000000.00
IBM balance_sheet (annual, 2021-12-31) — Investments And Advances: 1823000000.00
IBM balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 159000000.00
IBM balance_sheet (annual, 2021-12-31) — Liabilities Heldfor Sale Non Current: 0.00
IBM balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 159000000.00
IBM cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -1000000.00
IBM balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 1000000.00
IBM balance_sheet (annual, 2021-12-31) — Other Equity Interest: -1000000.00
IBM balance_sheet (annual, 2021-12-31) — Other Inventories: -1000000.00
IBM balance_sheet (annual, 2021-12-31) — Other Investments: 1823000000.00
IBM balance_sheet (annual, 2021-12-31) — Prepaid Assets: 3466000000.00
IBM cash_flow (annual, 2021-12-31) — Sale Of Business: 114000000.00
IBM balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 72000000.00
IBM income_statement (annual, 2022-12-31) — +Operating Expense: 24513000000.00
IBM income_statement (annual, 2022-12-31) — +Total Revenue: 60530000000.00
IBM balance_sheet (annual, 2022-12-31) — Accounts Payable: 4051000000.00
IBM balance_sheet (annual, 2022-12-31) — Accounts Receivable: 6541000000.00
IBM balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -13361000000.00
IBM balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -233000000.00
IBM income_statement (annual, 2022-12-31) — Amortization: 1062000000.00
IBM cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2395000000.00
IBM cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 2395000000.00
IBM income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 1062000000.00
IBM balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 939000000.00
IBM income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
IBM income_statement (annual, 2022-12-31) — Basic Average Shares: 902700000.00
IBM income_statement (annual, 2022-12-31) — Basic EPS: 1.82
IBM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6957000000.00
IBM balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 5678000000.00
IBM cash_flow (annual, 2022-12-31) — Capital Expenditure: -1972000000.00
IBM balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3064000000.00
IBM balance_sheet (annual, 2022-12-31) — Capital Stock: 58343000000.00
IBM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7886000000.00
IBM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 8738000000.00
IBM cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -5948000000.00
IBM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4958000000.00
IBM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -4202000000.00
IBM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 10435000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Account Payable: 213000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Inventory: 71000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 457000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Payable: 213000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 213000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Receivables: -539000000.00
IBM cash_flow (annual, 2022-12-31) — Change In Working Capital: 202000000.00
IBM cash_flow (annual, 2022-12-31) — Changes In Cash: 1275000000.00
IBM balance_sheet (annual, 2022-12-31) — Common Stock: 58343000000.00
IBM cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -5948000000.00
IBM balance_sheet (annual, 2022-12-31) — Common Stock Equity: 21944000000.00
IBM cash_flow (annual, 2022-12-31) — Common Stock Issuance: 279000000.00
IBM cash_flow (annual, 2022-12-31) — Common Stock Payments: -407000000.00
IBM income_statement (annual, 2022-12-31) — Cost Of Revenue: 27842000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 4111000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Assets: 29118000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 874000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Debt: 4760000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5634000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 967000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 12032000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 12032000000.00
IBM balance_sheet (annual, 2022-12-31) — Current Liabilities: 31505000000.00
IBM cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2726000000.00
IBM cash_flow (annual, 2022-12-31) — Deferred Tax: -2726000000.00
IBM balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 8236000000.00
IBM cash_flow (annual, 2022-12-31) — Depreciation: 2407000000.00
IBM cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 4802000000.00
IBM income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1062000000.00
IBM cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 4802000000.00
IBM income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1062000000.00
IBM balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 488000000.00
IBM income_statement (annual, 2022-12-31) — Diluted Average Shares: 912300000.00
IBM income_statement (annual, 2022-12-31) — Diluted EPS: 1.80
IBM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1639000000.00
IBM income_statement (annual, 2022-12-31) — EBIT: 2372000000.00
IBM income_statement (annual, 2022-12-31) — EBITDA: 7174000000.00
IBM cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -244000000.00
IBM balance_sheet (annual, 2022-12-31) — Employee Benefits: 11206000000.00
IBM cash_flow (annual, 2022-12-31) — End Cash Position: 7988000000.00
IBM cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4958000000.00
IBM balance_sheet (annual, 2022-12-31) — Finished Goods: 158000000.00
IBM cash_flow (annual, 2022-12-31) — Free Cash Flow: 8463000000.00
IBM cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -363000000.00
IBM income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 21000000.00
IBM income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 140000000.00
IBM balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -16740000000.00
IBM income_statement (annual, 2022-12-31) — General And Administrative Expense: 16103000000.00
IBM balance_sheet (annual, 2022-12-31) — Goodwill: 55949000000.00
IBM balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 67133000000.00
IBM balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 6774000000.00
IBM balance_sheet (annual, 2022-12-31) — Gross PPE: 21573000000.00
IBM income_statement (annual, 2022-12-31) — Gross Profit: 32687000000.00
IBM cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1865000000.00
IBM income_statement (annual, 2022-12-31) — Interest Expense: 1216000000.00
IBM income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1216000000.00
IBM income_statement (annual, 2022-12-31) — Interest Income: 162000000.00
IBM income_statement (annual, 2022-12-31) — Interest Income Non Operating: 162000000.00
IBM cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1401000000.00
IBM balance_sheet (annual, 2022-12-31) — Inventory: 1552000000.00
IBM balance_sheet (annual, 2022-12-31) — Invested Capital: 72893000000.00
IBM cash_flow (annual, 2022-12-31) — Investing Cash Flow: -4202000000.00
IBM balance_sheet (annual, 2022-12-31) — Investments And Advances: 1617000000.00
IBM cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 279000000.00
IBM cash_flow (annual, 2022-12-31) — Issuance Of Debt: 7804000000.00
IBM balance_sheet (annual, 2022-12-31) — Land And Improvements: 213000000.00
IBM balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2190000000.00
IBM balance_sheet (annual, 2022-12-31) — Long Term Debt: 46189000000.00
IBM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 48379000000.00
IBM cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 7804000000.00
IBM cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -6800000000.00
IBM balance_sheet (annual, 2022-12-31) — Long Term Provisions: 6404000000.00
IBM balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 9643000000.00
IBM balance_sheet (annual, 2022-12-31) — Minority Interest: 77000000.00
IBM cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1076000000.00
IBM cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -128000000.00
IBM balance_sheet (annual, 2022-12-31) — Net Debt: 43063000000.00
IBM income_statement (annual, 2022-12-31) — Net Income: 1640000000.00
IBM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1639000000.00
IBM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1783000000.00
IBM income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -143000000.00
IBM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1640000000.00
IBM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1783000000.00
IBM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1639000000.00
IBM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1640000000.00
IBM cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -626000000.00
IBM income_statement (annual, 2022-12-31) — Net Interest Income: -1054000000.00
IBM cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1265000000.00
IBM cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1221000000.00
IBM cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1004000000.00
IBM income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1054000000.00
IBM cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -103000000.00
IBM balance_sheet (annual, 2022-12-31) — Net PPE: 8212000000.00
IBM cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1235000000.00
IBM cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 217000000.00
IBM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -45189000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 5806000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 243000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 7122000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5791000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 3499000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 6256000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2292000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10903000000.00
IBM balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 8236000000.00
IBM income_statement (annual, 2022-12-31) — Normalized EBITDA: 7034000000.00
IBM income_statement (annual, 2022-12-31) — Normalized Income: 1672400000.00
IBM cash_flow (annual, 2022-12-31) — Operating Cash Flow: 10435000000.00
IBM cash_flow (annual, 2022-12-31) — Operating Gains Losses: 5531000000.00
IBM income_statement (annual, 2022-12-31) — Operating Income: 8174000000.00
IBM income_statement (annual, 2022-12-31) — Operating Revenue: 60530000000.00
IBM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 906091977.00
IBM balance_sheet (annual, 2022-12-31) — Other Current Assets: 2610000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4760000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -16740000000.00
IBM income_statement (annual, 2022-12-31) — Other Gand A: 15537000000.00
IBM income_statement (annual, 2022-12-31) — Other Income Expense: -5965000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 11184000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Investments: 1617000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1617000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1206000000.00
IBM income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -6105000000.00
IBM income_statement (annual, 2022-12-31) — Other Operating Expenses: -663000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Properties: 6039000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Receivables: 7668000000.00
IBM balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 852000000.00
IBM balance_sheet (annual, 2022-12-31) — Payables: 6247000000.00
IBM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 10358000000.00
IBM cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 5894000000.00
IBM balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3481000000.00
IBM income_statement (annual, 2022-12-31) — Pretax Income: 1156000000.00
IBM balance_sheet (annual, 2022-12-31) — Properties: 0.00
IBM income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 64000000.00
IBM cash_flow (annual, 2022-12-31) — Purchase Of Business: -2348000000.00
IBM cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -626000000.00
IBM cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5930000000.00
IBM cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1346000000.00
IBM balance_sheet (annual, 2022-12-31) — Receivables: 14209000000.00
IBM income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 27842000000.00
IBM income_statement (annual, 2022-12-31) — Reconciled Depreciation: 4802000000.00
IBM cash_flow (annual, 2022-12-31) — Repayment Of Debt: -6800000000.00
IBM cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -407000000.00
IBM income_statement (annual, 2022-12-31) — Research And Development: 6567000000.00
IBM balance_sheet (annual, 2022-12-31) — Restricted Cash: 103000000.00
IBM income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 50000000.00
IBM balance_sheet (annual, 2022-12-31) — Retained Earnings: 149825000000.00
IBM income_statement (annual, 2022-12-31) — Salaries And Wages: 566000000.00
IBM cash_flow (annual, 2022-12-31) — Sale Of Business: 1272000000.00
IBM cash_flow (annual, 2022-12-31) — Sale Of Investment: 4665000000.00
IBM cash_flow (annual, 2022-12-31) — Sale Of PPE: 111000000.00
IBM income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1330000000.00
IBM income_statement (annual, 2022-12-31) — Selling General And Administration: 18609000000.00
IBM balance_sheet (annual, 2022-12-31) — Share Issued: 2257116920.00
IBM income_statement (annual, 2022-12-31) — Special Income Charges: -29000000.00
IBM cash_flow (annual, 2022-12-31) — Stock Based Compensation: 987000000.00
IBM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 21944000000.00
IBM balance_sheet (annual, 2022-12-31) — Tangible Book Value: -45189000000.00
IBM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 29400000.00
IBM income_statement (annual, 2022-12-31) — Tax Provision: -626000000.00
IBM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
IBM balance_sheet (annual, 2022-12-31) — Total Assets: 127243000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Capitalization: 68133000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Debt: 54013000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 22021000000.00
IBM income_statement (annual, 2022-12-31) — Total Expenses: 52355000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 105222000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 98126000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 73717000000.00
IBM balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2196000000.00
IBM income_statement (annual, 2022-12-31) — Total Unusual Items: 140000000.00
IBM income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 140000000.00
IBM balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 90000000.00
IBM balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 1351024943.00
IBM balance_sheet (annual, 2022-12-31) — Treasury Stock: 169484000000.00
IBM balance_sheet (annual, 2022-12-31) — Work In Process: 1394000000.00
IBM balance_sheet (annual, 2022-12-31) — Working Capital: -2387000000.00
IBM income_statement (annual, 2023-12-31) — +Operating Expense: 24918000000.00
IBM income_statement (annual, 2023-12-31) — +Total Revenue: 61860000000.00
IBM balance_sheet (annual, 2023-12-31) — Accounts Payable: 4132000000.00
IBM balance_sheet (annual, 2023-12-31) — Accounts Receivable: 7214000000.00
IBM balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -12621000000.00
IBM balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -192000000.00
IBM income_statement (annual, 2023-12-31) — Amortization: 995000000.00
IBM cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2287000000.00
IBM cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2287000000.00
IBM income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 995000000.00
IBM balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 692000000.00
IBM income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
IBM income_statement (annual, 2023-12-31) — Basic Average Shares: 911200000.00
IBM income_statement (annual, 2023-12-31) — Basic EPS: 8.23
IBM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7988000000.00
IBM balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 5333000000.00
IBM cash_flow (annual, 2023-12-31) — Capital Expenditure: -1810000000.00
IBM balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3388000000.00
IBM balance_sheet (annual, 2023-12-31) — Capital Stock: 59643000000.00
IBM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 13068000000.00
IBM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 13441000000.00
IBM cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -6040000000.00
IBM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1770000000.00
IBM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -7071000000.00
IBM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 13931000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Account Payable: 65000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Inventory: 390000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 1004000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Payable: 65000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 65000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Receivables: 725000000.00
IBM cash_flow (annual, 2023-12-31) — Change In Working Capital: 2184000000.00
IBM cash_flow (annual, 2023-12-31) — Changes In Cash: 5092000000.00
IBM balance_sheet (annual, 2023-12-31) — Common Stock: 59643000000.00
IBM cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -6040000000.00
IBM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 22533000000.00
IBM cash_flow (annual, 2023-12-31) — Common Stock Issuance: 414000000.00
IBM cash_flow (annual, 2023-12-31) — Common Stock Payments: -402000000.00
IBM income_statement (annual, 2023-12-31) — Cost Of Revenue: 27560000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 3521000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Assets: 32908000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 820000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Debt: 6426000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 7246000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 998000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 13451000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 13451000000.00
IBM balance_sheet (annual, 2023-12-31) — Current Liabilities: 34122000000.00
IBM cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1114000000.00
IBM cash_flow (annual, 2023-12-31) — Deferred Tax: -1114000000.00
IBM balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 7506000000.00
IBM cash_flow (annual, 2023-12-31) — Depreciation: 2109000000.00
IBM cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4396000000.00
IBM income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 995000000.00
IBM cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4396000000.00
IBM income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 995000000.00
IBM balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 299000000.00
IBM income_statement (annual, 2023-12-31) — Diluted Average Shares: 922100000.00
IBM income_statement (annual, 2023-12-31) — Diluted EPS: 8.14
IBM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 7502000000.00
IBM income_statement (annual, 2023-12-31) — EBIT: 10297000000.00
IBM income_statement (annual, 2023-12-31) — EBITDA: 14693000000.00
IBM cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 9000000.00
IBM balance_sheet (annual, 2023-12-31) — Employee Benefits: 12553000000.00
IBM cash_flow (annual, 2023-12-31) — End Cash Position: 13089000000.00
IBM cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1769000000.00
IBM balance_sheet (annual, 2023-12-31) — Finished Goods: 78000000.00
IBM cash_flow (annual, 2023-12-31) — Free Cash Flow: 12121000000.00
IBM cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -170000000.00
IBM income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 8000000.00
IBM income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -60000000.00
IBM balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -18761000000.00
IBM income_statement (annual, 2023-12-31) — General And Administrative Expense: 16322000000.00
IBM balance_sheet (annual, 2023-12-31) — Goodwill: 60178000000.00
IBM balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 71214000000.00
IBM balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 7406000000.00
IBM balance_sheet (annual, 2023-12-31) — Gross PPE: 21343000000.00
IBM income_statement (annual, 2023-12-31) — Gross Profit: 34300000000.00
IBM cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1564000000.00
IBM income_statement (annual, 2023-12-31) — Interest Expense: 1607000000.00
IBM income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1607000000.00
IBM income_statement (annual, 2023-12-31) — Interest Income: 670000000.00
IBM income_statement (annual, 2023-12-31) — Interest Income Non Operating: 670000000.00
IBM cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1668000000.00
IBM balance_sheet (annual, 2023-12-31) — Inventory: 1161000000.00
IBM balance_sheet (annual, 2023-12-31) — Invested Capital: 79080000000.00
IBM cash_flow (annual, 2023-12-31) — Investing Cash Flow: -7070000000.00
IBM cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 414000000.00
IBM cash_flow (annual, 2023-12-31) — Issuance Of Debt: 9586000000.00
IBM balance_sheet (annual, 2023-12-31) — Land And Improvements: 182000000.00
IBM balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2568000000.00
IBM balance_sheet (annual, 2023-12-31) — Long Term Debt: 50121000000.00
IBM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 52689000000.00
IBM cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 9586000000.00
IBM cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5082000000.00
IBM balance_sheet (annual, 2023-12-31) — Long Term Provisions: 6916000000.00
IBM balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 9223000000.00
IBM balance_sheet (annual, 2023-12-31) — Minority Interest: 80000000.00
IBM cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -5086000000.00
IBM cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 12000000.00
IBM balance_sheet (annual, 2023-12-31) — Net Debt: 43479000000.00
IBM income_statement (annual, 2023-12-31) — Net Income: 7502000000.00
IBM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 7502000000.00
IBM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 7514000000.00
IBM income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -12000000.00
IBM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 7502000000.00
IBM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 7514000000.00
IBM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 7502000000.00
IBM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 7502000000.00
IBM cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -565000000.00
IBM income_statement (annual, 2023-12-31) — Net Interest Income: -937000000.00
IBM cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -496000000.00
IBM cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 4497000000.00
IBM cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 4504000000.00
IBM income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -937000000.00
IBM cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -238000000.00
IBM cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1000000.00
IBM balance_sheet (annual, 2023-12-31) — Net PPE: 8722000000.00
IBM cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -924000000.00
IBM cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -7000000.00
IBM balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -48681000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 5766000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 206000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 7498000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4679000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 3533000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 6656000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1146000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12245000000.00
IBM balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 7506000000.00
IBM income_statement (annual, 2023-12-31) — Normalized EBITDA: 14753000000.00
IBM income_statement (annual, 2023-12-31) — Normalized Income: 7565900000.00
IBM cash_flow (annual, 2023-12-31) — Operating Cash Flow: 13931000000.00
IBM cash_flow (annual, 2023-12-31) — Operating Gains Losses: -170000000.00
IBM income_statement (annual, 2023-12-31) — Operating Income: 9382000000.00
IBM income_statement (annual, 2023-12-31) — Operating Revenue: 61860000000.00
IBM balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 915013646.00
IBM balance_sheet (annual, 2023-12-31) — Other Current Assets: 2639000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 6426000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -18761000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Equity Interest: -1000000.00
IBM income_statement (annual, 2023-12-31) — Other Gand A: 15706000000.00
IBM income_statement (annual, 2023-12-31) — Other Income Expense: 245000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 11036000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1626000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1164000000.00
IBM income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 305000000.00
IBM income_statement (annual, 2023-12-31) — Other Operating Expenses: -860000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Properties: 6605000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Receivables: 6742000000.00
IBM balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 373000000.00
IBM balance_sheet (annual, 2023-12-31) — Payables: 6402000000.00
IBM balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 9923000000.00
IBM cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 0.00
IBM balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3501000000.00
IBM income_statement (annual, 2023-12-31) — Pretax Income: 8690000000.00
IBM balance_sheet (annual, 2023-12-31) — Properties: 0.00
IBM income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 10000000.00
IBM cash_flow (annual, 2023-12-31) — Purchase Of Business: -5086000000.00
IBM cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -565000000.00
IBM cash_flow (annual, 2023-12-31) — Purchase Of Investment: -11143000000.00
IBM cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1245000000.00
IBM balance_sheet (annual, 2023-12-31) — Receivables: 13956000000.00
IBM income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 27560000000.00
IBM income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4396000000.00
IBM cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5082000000.00
IBM cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -402000000.00
IBM income_statement (annual, 2023-12-31) — Research And Development: 6775000000.00
IBM balance_sheet (annual, 2023-12-31) — Restricted Cash: 21000000.00
IBM income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 438000000.00
IBM balance_sheet (annual, 2023-12-31) — Retained Earnings: 151276000000.00
IBM income_statement (annual, 2023-12-31) — Salaries And Wages: 616000000.00
IBM cash_flow (annual, 2023-12-31) — Sale Of Investment: 10647000000.00
IBM cash_flow (annual, 2023-12-31) — Sale Of PPE: 321000000.00
IBM income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1237000000.00
IBM income_statement (annual, 2023-12-31) — Selling General And Administration: 19003000000.00
IBM balance_sheet (annual, 2023-12-31) — Share Issued: 2266911159.00
IBM income_statement (annual, 2023-12-31) — Special Income Charges: -430000000.00
IBM cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1133000000.00
IBM balance_sheet (annual, 2023-12-31) — Stockholders Equity: 22533000000.00
IBM balance_sheet (annual, 2023-12-31) — Tangible Book Value: -48681000000.00
IBM income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -8100000.00
IBM income_statement (annual, 2023-12-31) — Tax Provision: 1176000000.00
IBM income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.14
IBM balance_sheet (annual, 2023-12-31) — Total Assets: 135241000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Capitalization: 72654000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Debt: 59935000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 22613000000.00
IBM income_statement (annual, 2023-12-31) — Total Expenses: 52478000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 112628000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 102332000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 78506000000.00
IBM balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2270000000.00
IBM income_statement (annual, 2023-12-31) — Total Unusual Items: -60000000.00
IBM income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -60000000.00
IBM balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 1351897513.00
IBM balance_sheet (annual, 2023-12-31) — Treasury Stock: 169624000000.00
IBM balance_sheet (annual, 2023-12-31) — Work In Process: 1083000000.00
IBM balance_sheet (annual, 2023-12-31) — Working Capital: -1214000000.00
IBM balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: -1000000.00
IBM balance_sheet (quarterly, 2024-09-30) — Other Inventories: -1000000.00
IBM cash_flow (quarterly, 2024-09-30) — Sale Of Business: 2000000.00
IBM income_statement (annual, 2024-12-31) — +Operating Expense: 25477000000.00
IBM income_statement (annual, 2024-12-31) — +Total Revenue: 62753000000.00
IBM balance_sheet (annual, 2024-12-31) — Accounts Payable: 4032000000.00
IBM balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6804000000.00
IBM balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -11959000000.00
IBM balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -114000000.00
IBM income_statement (annual, 2024-12-31) — Amortization: 1105000000.00
IBM cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 2499000000.00
IBM cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 2499000000.00
IBM income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 1105000000.00
IBM balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 900000000.00
IBM income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
IBM income_statement (annual, 2024-12-31) — Basic Average Shares: 921800000.00
IBM income_statement (annual, 2024-12-31) — Basic EPS: 6.53
IBM cash_flow (annual, 2024-12-31) — Beginning Cash Position: 13089000000.00
IBM balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4825000000.00
IBM balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4825000000.00
IBM cash_flow (annual, 2024-12-31) — Capital Expenditure: -1685000000.00
IBM balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3423000000.00
IBM balance_sheet (annual, 2024-12-31) — Capital Stock: 61380000000.00
IBM balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 13947000000.00
IBM balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 14591000000.00
IBM cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -6147000000.00
IBM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -7078000000.00
IBM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -4937000000.00
IBM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 13445000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Account Payable: -13000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Inventory: -166000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 1866000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Payable: -13000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -13000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Receivables: -374000000.00
IBM cash_flow (annual, 2024-12-31) — Change In Working Capital: 1313000000.00
IBM cash_flow (annual, 2024-12-31) — Changes In Cash: 1430000000.00